齐典文;郭卫;杨荣利;李大森;李晓;姬涛;李广学;

• 1:北京大学人民医院骨与软组织肿瘤中心

摘要(Abstract)：

[目的]比较18F-FDG PET/CT与传统影像检查(胸片、彩超、CT及MRI等)为骨转移瘤患者寻找原发灶的临床价值。[方法]回顾性分析37例于2008年5月~2010年6月间本中心收治的经病理证实的骨转移瘤患者的病例资料,并随访其后续的诊治情况。以病理结果或临床随访作为原发灶确认标准。并将PET/CT与传统影像检查对原发灶的检出情况进行比较。且对治疗方案的调整进行汇总。[结果]37例患者中,PET/CT提示原发灶28例,其中正确检出原发灶27例(73%),1例为假阳性;传统影像检查正确检出原发灶17例(46%),两者原发灶正确检出率的差异有显著性(x2=5.61,P=0.018)。27例经PET/CT正确检出原发灶的病例中,17例(63%)采取了针对原发灶的治疗措施。此外9例PET/CT未提示原发灶的患者中,3例经病理证实为假阴性。[结论]与传统影像检查相比,18F-FDG PET/CT可更有效、更便捷的找出骨转移瘤患者原发灶,进而为制定更合理的治疗方案提供依据。

关键词(KeyWords)： 正电子发射计算机体层摄影/计算机断层扫描;骨转移瘤;原发灶

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 齐典文;郭卫;杨荣利;李大森;李晓;姬涛;李广学;

Email:

DOI:

参考文献(References)：

• [1]Le Chevalier T,Cvitkovic E,Caille P,et al.Early metastatic cancer ofunknown primary origin at presentation.Aclinical study of302 consecu-tive autopsied patients[J].Arch Intern Med,1988,9:2035-2039.
• [2]Abbruzzese JL,Abbruzzese MC,Lenzi R,et al.Analysis of a diagnos-tic strategy for patients with suspected tumors of unknown origin[J].JClin Oncol,1995,8:2094-2103.
• [3]Ambrosini V,Nanni C,Rubello D,et al.18F-FDG PET/CT in theassessment of carcinoma of unknown primary origin[J].Radiol Med,2006,8:1146-1155.
• [4]Pelosi E,Pennone M,Deandreis D,et al.Role of whole body positronemission tomography/computed tomography scan with18F-fluorode-oxyglucose in patients with biopsy proven tumor metastases from un-known primary site[J].QJ Nucl Med Mol Imaging,2006,1:15-22.
• [5]Pakzad F,Groves AM,Ell PJ.The role of positron emission tomo-graphy in the management of pancreatic cancer[J].Semin Nucl Med,2006,3:248-256.
• [6]Demir H,Berk F,Raderer M,et al.The role of nuclear medicine inthe diagnosis of cancer of unknown origin[J].QJ Nucl Med Mol Ima-ging,2004,2:164-173.
• [7]Freudenberg LS,Fischer M,Antoch G,et al.Dual modality of18F-fluorodeoxyglucose-positron emission tomography/computed tomo-graphy in patients with cervical carcinoma of unknown primary[J].Med Princ Pract,2005,3:155-160.
• [8]De Wever W,Ceyssens S,Mortelmans L,et al.Additional value ofPET-CT in the staging of lung cancer:comparison with CT alone,PETalone and visual correlation of PET and CT[J].Eur Radiol,2007,1:23-32.
• [9]Lardinois D,Weder W,Hany TF,et al.Staging of non-small-celllung cancer with integrated positron-emission tomography and com-puted tomography[J].N Engl J Med,2003,25:2500-2507.
• [10]Kwee TC,Kwee R M.Combined FDG-PET/CTfor the detection ofunknown primary tumors:systematic review and meta-analysis[J].Eur Radiol,2009,3:731-744.
• [11]Al-Brahim N,Ross C,Carter B,et al.The value of postmortem ex-amination in cases of metastasis of unknown origin-20-year retro-spective data from a tertiary care center[J].Ann Diagn Pathol,2005,2:77-80.
• [12]van Waarde A,Cobben DC,Suurmeijer AJ,et al.Selectivity of18F-FLTand18F-FDG for differentiating tumor frominflammation in a ro-dent model[J].J Nucl Med,2004,4:695-700.
• [13]Nomori H,Watanabe K,Ohtsuka T,et al.Evaluation of F-18 fluoro-deoxyglucose(FDG)PETscanning for pulmonary nodules less than 3cm in diameter,with special reference to the CT images[J].LungCancer,2004,1:19-27.
• [14]Berger KL,Nicholson SA,Dehdashti F,et al.FDG PETevaluation ofmucinous neoplasms:correlation of FDG uptake with histopathologicfeatures[J].AJR Am J Roentgenol,2000,4:1005-1008.